Nofazinlimab (CS1003)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Nofazinlimab (CS1003), covering 2025-12-11 to 2026-07-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma [Phase 3]